Share Price and Basic Stock Data
Last Updated: June 25, 2025, 8:00 pm
PEG Ratio | -2.38 |
---|
Competitors of UPL Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Epigral Ltd | 7,929 Cr. | 1,838 | 2,408/1,302 | 22.6 | 441 | 0.34 % | 24.9 % | 22.3 % | 10.0 |
Dharmaj Crop Guard Ltd | 1,031 Cr. | 305 | 390/165 | 29.6 | 117 | 0.00 % | 12.0 % | 9.24 % | 10.0 |
Bhaskar Agrochemicals Ltd | 56.7 Cr. | 109 | 148/55.2 | 14.5 | 34.1 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
Bhagiradha Chemicals & Industries Ltd | 3,813 Cr. | 294 | 448/247 | 139 | 53.9 | 0.03 % | 7.44 % | 4.91 % | 1.00 |
Best Agrolife Ltd | 756 Cr. | 320 | 713/244 | 10.8 | 320 | 0.91 % | 12.9 % | 9.95 % | 10.0 |
Industry Average | 12,070.05 Cr | 1,658.35 | 37.10 | 435.98 | 0.31% | 15.26% | 19.94% | 7.25 |
Quarterly Result
Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 15,861 | 10,821 | 12,507 | 13,679 | 16,569 | 8,963 | 10,170 | 9,887 | 14,078 | 9,067 | 11,090 | 10,907 | 15,573 |
Expenses | 12,481 | 8,675 | 10,090 | 10,795 | 13,847 | 7,747 | 9,049 | 9,820 | 12,230 | 7,998 | 9,873 | 9,229 | 12,409 |
Operating Profit | 3,380 | 2,146 | 2,417 | 2,884 | 2,722 | 1,216 | 1,121 | 67 | 1,848 | 1,069 | 1,217 | 1,678 | 3,164 |
OPM % | 21% | 20% | 19% | 21% | 16% | 14% | 11% | 1% | 13% | 12% | 11% | 15% | 20% |
Other Income | 62 | 25 | 35 | 129 | 302 | 58 | 18 | 134 | 66 | 49 | 103 | 94 | -168 |
Interest | 800 | 519 | 644 | 894 | 906 | 700 | 871 | 1,191 | 1,090 | 913 | 1,070 | 730 | 914 |
Depreciation | 642 | 588 | 608 | 624 | 727 | 636 | 657 | 676 | 794 | 660 | 697 | 688 | 705 |
Profit before tax | 2,000 | 1,064 | 1,200 | 1,495 | 1,391 | -62 | -389 | -1,666 | 30 | -455 | -447 | 354 | 1,377 |
Tax % | 13% | 6% | 19% | 9% | 22% | -265% | -25% | -4% | 367% | 16% | 31% | -141% | 22% |
Net Profit | 1,735 | 1,005 | 969 | 1,360 | 1,080 | 102 | -293 | -1,607 | -80 | -527 | -585 | 853 | 1,079 |
EPS in Rs | 16.04 | 10.39 | 9.64 | 12.87 | 9.38 | 1.97 | -2.24 | -14.41 | 0.47 | -4.55 | -5.25 | 9.81 | 10.61 |
Last Updated: May 31, 2025, 7:24 am
Below is a detailed analysis of the quarterly data for UPL Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 15,573.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,907.00 Cr. (Dec 2024) to 15,573.00 Cr., marking an increase of 4,666.00 Cr..
- For Expenses, as of Mar 2025, the value is 12,409.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,229.00 Cr. (Dec 2024) to 12,409.00 Cr., marking an increase of 3,180.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 3,164.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,678.00 Cr. (Dec 2024) to 3,164.00 Cr., marking an increase of 1,486.00 Cr..
- For OPM %, as of Mar 2025, the value is 20.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Dec 2024) to 20.00%, marking an increase of 5.00%.
- For Other Income, as of Mar 2025, the value is -168.00 Cr.. The value appears to be declining and may need further review. It has decreased from 94.00 Cr. (Dec 2024) to -168.00 Cr., marking a decrease of 262.00 Cr..
- For Interest, as of Mar 2025, the value is 914.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 730.00 Cr. (Dec 2024) to 914.00 Cr., marking an increase of 184.00 Cr..
- For Depreciation, as of Mar 2025, the value is 705.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 688.00 Cr. (Dec 2024) to 705.00 Cr., marking an increase of 17.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 1,377.00 Cr.. The value appears strong and on an upward trend. It has increased from 354.00 Cr. (Dec 2024) to 1,377.00 Cr., marking an increase of 1,023.00 Cr..
- For Tax %, as of Mar 2025, the value is 22.00%. The value appears to be increasing, which may not be favorable. It has increased from -141.00% (Dec 2024) to 22.00%, marking an increase of 163.00%.
- For Net Profit, as of Mar 2025, the value is 1,079.00 Cr.. The value appears strong and on an upward trend. It has increased from 853.00 Cr. (Dec 2024) to 1,079.00 Cr., marking an increase of 226.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 10.61. The value appears strong and on an upward trend. It has increased from 9.81 (Dec 2024) to 10.61, marking an increase of 0.80.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: May 15, 2025, 4:53 am
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 10,771 | 12,091 | 14,048 | 16,312 | 17,378 | 21,837 | 35,756 | 38,694 | 46,240 | 53,576 | 43,098 | 46,637 |
Expenses | 8,753 | 9,728 | 11,700 | 13,346 | 13,966 | 18,024 | 28,984 | 30,342 | 36,711 | 43,380 | 38,801 | 39,509 |
Operating Profit | 2,018 | 2,363 | 2,348 | 2,966 | 3,412 | 3,813 | 6,772 | 8,352 | 9,529 | 10,196 | 4,297 | 7,128 |
OPM % | 19% | 20% | 17% | 18% | 20% | 17% | 19% | 22% | 21% | 19% | 10% | 15% |
Other Income | 30 | -11 | 149 | 363 | 351 | -197 | -515 | 62 | 91 | 464 | 231 | 78 |
Interest | 485 | 517 | 704 | 735 | 783 | 963 | 1,481 | 2,060 | 2,295 | 2,963 | 3,852 | 3,627 |
Depreciation | 407 | 425 | 676 | 672 | 675 | 880 | 2,012 | 2,173 | 2,359 | 2,547 | 2,763 | 2,750 |
Profit before tax | 1,157 | 1,410 | 1,117 | 1,922 | 2,305 | 1,773 | 2,764 | 4,181 | 4,966 | 5,150 | -2,087 | 829 |
Tax % | 19% | 17% | 15% | 10% | 12% | 11% | 21% | 16% | 11% | 14% | -10% | 1% |
Net Profit | 957 | 1,187 | 952 | 1,733 | 2,030 | 1,575 | 2,178 | 3,495 | 4,437 | 4,414 | -1,878 | 820 |
EPS in Rs | 13.13 | 15.82 | 13.00 | 20.18 | 23.57 | 17.35 | 20.66 | 33.40 | 42.18 | 42.28 | -14.21 | 10.62 |
Dividend Payout % | 18% | 19% | 23% | 20% | 20% | 27% | 26% | 27% | 21% | 21% | -6% | 53% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 24.03% | -19.80% | 82.04% | 17.14% | -22.41% | 38.29% | 60.47% | 26.95% | -0.52% | -142.55% | 143.66% |
Change in YoY Net Profit Growth (%) | 0.00% | -43.83% | 101.84% | -64.90% | -39.55% | 60.70% | 22.18% | -33.52% | -27.47% | -142.03% | 286.21% |
UPL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 5% |
3 Years: | 0% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | -1% |
5 Years: | -13% |
3 Years: | -34% |
TTM: | 198% |
Stock Price CAGR | |
---|---|
10 Years: | 7% |
5 Years: | 9% |
3 Years: | 1% |
1 Year: | 19% |
Return on Equity | |
---|---|
10 Years: | 11% |
5 Years: | 9% |
3 Years: | 5% |
Last Year: | 4% |
Last Updated: Unknown
Balance Sheet
Last Updated: May 13, 2025, 2:30 pm
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 86 | 86 | 86 | 101 | 102 | 102 | 153 | 153 | 153 | 150 | 150 | 159 |
Reserves | 5,162 | 5,775 | 5,803 | 7,214 | 9,067 | 14,613 | 19,129 | 20,734 | 24,508 | 26,708 | 24,657 | 29,054 |
Borrowings | 3,349 | 3,281 | 5,258 | 6,443 | 6,638 | 29,139 | 29,388 | 24,519 | 26,746 | 23,939 | 29,754 | 25,099 |
Other Liabilities | 4,162 | 5,143 | 5,722 | 6,454 | 7,148 | 18,581 | 19,758 | 23,359 | 29,196 | 35,318 | 30,579 | 33,690 |
Total Liabilities | 12,759 | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 88,002 |
Fixed Assets | 3,821 | 4,031 | 3,862 | 4,071 | 4,437 | 32,149 | 35,321 | 34,765 | 36,193 | 38,713 | 39,056 | 41,015 |
CWIP | 228 | 583 | 484 | 792 | 1,319 | 1,855 | 2,073 | 2,117 | 2,501 | 2,818 | 2,965 | 615 |
Investments | 737 | 764 | 335 | 378 | 1,034 | 708 | 558 | 618 | 1,922 | 1,615 | 2,154 | 2,328 |
Other Assets | 7,973 | 8,906 | 12,188 | 14,971 | 16,165 | 27,723 | 30,476 | 31,265 | 39,987 | 42,969 | 40,965 | 44,044 |
Total Assets | 12,759 | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 88,002 |
Below is a detailed analysis of the balance sheet data for UPL Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 159.00 Cr.. The value appears strong and on an upward trend. It has increased from 150.00 Cr. (Mar 2024) to 159.00 Cr., marking an increase of 9.00 Cr..
- For Reserves, as of Mar 2025, the value is 29,054.00 Cr.. The value appears strong and on an upward trend. It has increased from 24,657.00 Cr. (Mar 2024) to 29,054.00 Cr., marking an increase of 4,397.00 Cr..
- For Borrowings, as of Mar 2025, the value is 25,099.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 29,754.00 Cr. (Mar 2024) to 25,099.00 Cr., marking a decrease of 4,655.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 33,690.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30,579.00 Cr. (Mar 2024) to 33,690.00 Cr., marking an increase of 3,111.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 88,002.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 85,140.00 Cr. (Mar 2024) to 88,002.00 Cr., marking an increase of 2,862.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 41,015.00 Cr.. The value appears strong and on an upward trend. It has increased from 39,056.00 Cr. (Mar 2024) to 41,015.00 Cr., marking an increase of 1,959.00 Cr..
- For CWIP, as of Mar 2025, the value is 615.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,965.00 Cr. (Mar 2024) to 615.00 Cr., marking a decrease of 2,350.00 Cr..
- For Investments, as of Mar 2025, the value is 2,328.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,154.00 Cr. (Mar 2024) to 2,328.00 Cr., marking an increase of 174.00 Cr..
- For Other Assets, as of Mar 2025, the value is 44,044.00 Cr.. The value appears strong and on an upward trend. It has increased from 40,965.00 Cr. (Mar 2024) to 44,044.00 Cr., marking an increase of 3,079.00 Cr..
- For Total Assets, as of Mar 2025, the value is 88,002.00 Cr.. The value appears strong and on an upward trend. It has increased from 85,140.00 Cr. (Mar 2024) to 88,002.00 Cr., marking an increase of 2,862.00 Cr..
Notably, the Reserves (29,054.00 Cr.) exceed the Borrowings (25,099.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -1.00 | -1.00 | -3.00 | -4.00 | -3.00 | -26.00 | -23.00 | -16.00 | -17.00 | -13.00 | -25.00 | -18.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 107 | 109 | 115 | 133 | 127 | 127 | 195 | 121 | 115 | 121 | 124 | 138 |
Inventory Days | 161 | 166 | 178 | 204 | 194 | 204 | 306 | 153 | 180 | 216 | 187 | 190 |
Days Payable | 163 | 181 | 195 | 213 | 228 | 255 | 330 | 199 | 244 | 274 | 236 | 234 |
Cash Conversion Cycle | 104 | 95 | 98 | 124 | 93 | 76 | 171 | 75 | 51 | 64 | 76 | 95 |
Working Capital Days | 100 | 85 | 78 | 113 | 99 | 107 | 168 | 72 | 69 | 73 | 68 | 93 |
ROCE % | 16% | 19% | 21% | 19% | 22% | 21% | 10% | 10% | 13% | 14% | 14% | 3% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
SBI Nifty 50 ETF | 9,105,577 | 0.28 | 489.61 | 9,105,577 | 2025-04-22 17:25:16 | 0% |
UTI Nifty 50 ETF | 2,521,527 | 0.28 | 135.58 | 2,521,527 | 2025-04-22 17:25:16 | 0% |
SBI Arbitrage Opportunities Fund | 1,292,200 | 0.26 | 69.48 | 1,292,200 | 2025-04-22 17:25:16 | 0% |
Nippon India ETF Nifty 50 BeES | 1,075,205 | 0.28 | 57.81 | 1,075,205 | 2025-04-22 09:14:30 | 0% |
UTI Nifty 50 Index Fund | 810,001 | 0.28 | 43.55 | 810,001 | 2025-04-22 17:25:16 | 0% |
DSP Nifty 50 Equal Weight Index Fund | 341,976 | 1.79 | 18.39 | 341,976 | 2025-04-22 17:25:16 | 0% |
SBI Nifty Index Fund | 327,375 | 0.29 | 17.6 | 327,375 | 2025-04-22 17:25:16 | 0% |
SBI Nifty50 Equal Weight Index Fund | 290,494 | 1.73 | 15.62 | 290,494 | 2025-04-22 17:25:16 | 0% |
Nippon India Arbitrage Fund | 215,800 | 0.09 | 11.6 | 215,800 | 2025-04-22 17:25:16 | 0% |
Invesco India Arbitrage Fund | 163,800 | 0.08 | 9.62 | 163,800 | 2025-04-22 17:25:16 | 0% |
Key Financial Ratios
Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|---|
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Basic EPS (Rs.) | 9.85 | -17.80 | 45.79 | 45.87 | 36.40 |
Diluted EPS (Rs.) | 9.62 | -17.80 | 45.79 | 45.87 | 36.40 |
Cash EPS (Rs.) | 50.84 | 15.03 | 90.72 | 87.08 | 73.54 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 367.46 | 396.27 | 432.57 | 344.08 | 282.27 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 367.46 | 396.27 | 432.57 | 344.08 | 282.27 |
Revenue From Operations / Share (Rs.) | 586.63 | 574.64 | 714.35 | 604.44 | 505.80 |
PBDIT / Share (Rs.) | 101.71 | 66.96 | 142.31 | 128.24 | 112.55 |
PBIT / Share (Rs.) | 67.12 | 30.12 | 108.35 | 97.40 | 84.14 |
PBT / Share (Rs.) | 16.36 | -24.60 | 66.57 | 63.16 | 54.10 |
Net Profit / Share (Rs.) | 16.25 | -21.81 | 56.76 | 56.25 | 45.14 |
NP After MI And SOA / Share (Rs.) | 11.28 | -16.00 | 47.60 | 47.40 | 37.53 |
PBDIT Margin (%) | 17.33 | 11.65 | 19.92 | 21.21 | 22.25 |
PBIT Margin (%) | 11.44 | 5.24 | 15.16 | 16.11 | 16.63 |
PBT Margin (%) | 2.78 | -4.28 | 9.31 | 10.44 | 10.69 |
Net Profit Margin (%) | 2.77 | -3.79 | 7.94 | 9.30 | 8.92 |
NP After MI And SOA Margin (%) | 1.92 | -2.78 | 6.66 | 7.84 | 7.41 |
Return on Networth / Equity (%) | 3.07 | -4.83 | 13.29 | 16.72 | 16.03 |
Return on Capital Employeed (%) | 8.97 | 3.72 | 13.64 | 13.67 | 12.67 |
Return On Assets (%) | 1.01 | -1.37 | 4.03 | 4.38 | 4.07 |
Long Term Debt / Equity (X) | 0.62 | 0.96 | 0.75 | 0.99 | 1.24 |
Total Debt / Equity (X) | 0.81 | 1.15 | 0.85 | 1.19 | 1.32 |
Asset Turnover Ratio (%) | 0.53 | 0.48 | 0.37 | 0.36 | 0.26 |
Current Ratio (X) | 1.39 | 1.46 | 1.45 | 1.41 | 1.53 |
Quick Ratio (X) | 1.03 | 0.98 | 0.96 | 0.94 | 1.05 |
Inventory Turnover Ratio (X) | 2.10 | 1.83 | 1.45 | 1.41 | 1.15 |
Dividend Payout Ratio (NP) (%) | 0.00 | -62.41 | 21.03 | 21.07 | 15.95 |
Dividend Payout Ratio (CP) (%) | 0.00 | 47.92 | 12.27 | 12.76 | 9.08 |
Earning Retention Ratio (%) | 0.00 | 162.41 | 78.97 | 78.93 | 84.05 |
Cash Earning Retention Ratio (%) | 0.00 | 52.08 | 87.73 | 87.24 | 90.92 |
Interest Coverage Ratio (X) | 2.23 | 1.30 | 3.60 | 4.27 | 4.18 |
Interest Coverage Ratio (Post Tax) (X) | 1.47 | 0.64 | 2.49 | 3.02 | 2.79 |
Enterprise Value (Cr.) | 76512.87 | 61503.75 | 76295.75 | 83275.05 | 71528.30 |
EV / Net Operating Revenue (X) | 1.57 | 1.43 | 1.42 | 1.80 | 1.85 |
EV / EBITDA (X) | 9.07 | 12.25 | 7.15 | 8.49 | 8.31 |
MarketCap / Net Operating Revenue (X) | 1.08 | 0.79 | 1.00 | 1.27 | 1.27 |
Retention Ratios (%) | 0.00 | 162.41 | 78.96 | 78.92 | 84.04 |
Price / BV (X) | 1.73 | 1.38 | 2.00 | 2.72 | 2.74 |
Price / Net Operating Revenue (X) | 1.08 | 0.79 | 1.00 | 1.27 | 1.27 |
EarningsYield | 0.01 | -0.03 | 0.06 | 0.06 | 0.05 |
After reviewing the key financial ratios for UPL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 9.85. This value is within the healthy range. It has increased from -17.80 (Mar 24) to 9.85, marking an increase of 27.65.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.62. This value is within the healthy range. It has increased from -17.80 (Mar 24) to 9.62, marking an increase of 27.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 50.84. This value is within the healthy range. It has increased from 15.03 (Mar 24) to 50.84, marking an increase of 35.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 367.46. It has decreased from 396.27 (Mar 24) to 367.46, marking a decrease of 28.81.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 367.46. It has decreased from 396.27 (Mar 24) to 367.46, marking a decrease of 28.81.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 586.63. It has increased from 574.64 (Mar 24) to 586.63, marking an increase of 11.99.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 101.71. This value is within the healthy range. It has increased from 66.96 (Mar 24) to 101.71, marking an increase of 34.75.
- For PBIT / Share (Rs.), as of Mar 25, the value is 67.12. This value is within the healthy range. It has increased from 30.12 (Mar 24) to 67.12, marking an increase of 37.00.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.36. This value is within the healthy range. It has increased from -24.60 (Mar 24) to 16.36, marking an increase of 40.96.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 16.25. This value is within the healthy range. It has increased from -21.81 (Mar 24) to 16.25, marking an increase of 38.06.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.28. This value is within the healthy range. It has increased from -16.00 (Mar 24) to 11.28, marking an increase of 27.28.
- For PBDIT Margin (%), as of Mar 25, the value is 17.33. This value is within the healthy range. It has increased from 11.65 (Mar 24) to 17.33, marking an increase of 5.68.
- For PBIT Margin (%), as of Mar 25, the value is 11.44. This value is within the healthy range. It has increased from 5.24 (Mar 24) to 11.44, marking an increase of 6.20.
- For PBT Margin (%), as of Mar 25, the value is 2.78. This value is below the healthy minimum of 10. It has increased from -4.28 (Mar 24) to 2.78, marking an increase of 7.06.
- For Net Profit Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 5. It has increased from -3.79 (Mar 24) to 2.77, marking an increase of 6.56.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.92. This value is below the healthy minimum of 8. It has increased from -2.78 (Mar 24) to 1.92, marking an increase of 4.70.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.07. This value is below the healthy minimum of 15. It has increased from -4.83 (Mar 24) to 3.07, marking an increase of 7.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. It has increased from 3.72 (Mar 24) to 8.97, marking an increase of 5.25.
- For Return On Assets (%), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 5. It has increased from -1.37 (Mar 24) to 1.01, marking an increase of 2.38.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.62. This value is within the healthy range. It has decreased from 0.96 (Mar 24) to 0.62, marking a decrease of 0.34.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.81. This value is within the healthy range. It has decreased from 1.15 (Mar 24) to 0.81, marking a decrease of 0.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.53. It has increased from 0.48 (Mar 24) to 0.53, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.39, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has increased from 0.98 (Mar 24) to 1.03, marking an increase of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.10. This value is below the healthy minimum of 4. It has increased from 1.83 (Mar 24) to 2.10, marking an increase of 0.27.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -62.41 (Mar 24) to 0.00, marking an increase of 62.41.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 47.92 (Mar 24) to 0.00, marking a decrease of 47.92.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 162.41 (Mar 24) to 0.00, marking a decrease of 162.41.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 52.08 (Mar 24) to 0.00, marking a decrease of 52.08.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.23. This value is below the healthy minimum of 3. It has increased from 1.30 (Mar 24) to 2.23, marking an increase of 0.93.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 3. It has increased from 0.64 (Mar 24) to 1.47, marking an increase of 0.83.
- For Enterprise Value (Cr.), as of Mar 25, the value is 76,512.87. It has increased from 61,503.75 (Mar 24) to 76,512.87, marking an increase of 15,009.12.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has increased from 1.43 (Mar 24) to 1.57, marking an increase of 0.14.
- For EV / EBITDA (X), as of Mar 25, the value is 9.07. This value is within the healthy range. It has decreased from 12.25 (Mar 24) to 9.07, marking a decrease of 3.18.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.08, marking an increase of 0.29.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 162.41 (Mar 24) to 0.00, marking a decrease of 162.41.
- For Price / BV (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 1.73, marking an increase of 0.35.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.08, marking an increase of 0.29.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.03 (Mar 24) to 0.01, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in UPL Ltd:
- Net Profit Margin: 2.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.97% (Industry Average ROCE: 15.26%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.07% (Industry Average ROE: 19.94%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.47
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.03
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 48.8 (Industry average Stock P/E: 37.1)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.81
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.77%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Agro Chemicals/Pesticides | 3-11, G.I.D.C., Valsad District Gujarat 396195 | upl.investors@upl-ltd.com http://www.upl-ltd.com |
Management | |
---|---|
Name | Position Held |
Mr. Rajnikant D Shroff | Chairman Emeritus |
Mr. Jai Shroff | Chairman & Group CEO |
Mr. Vikram Shroff | Vice Chairman |
Mr. Raj Tiwari | Whole Time Director |
Mr. Carlos Pellicer | Non Executive Director |
Mr. Hardeep Singh | Lead Independent Director |
Dr. Vasant Gandhi | Independent Director |
Ms. Naina Lal Kidwai | Independent Director |
Mr. Suresh Kumar | Independent Director |
Ms. Usha Monari | Independent Director |
FAQ
What is the intrinsic value of UPL Ltd?
UPL Ltd's intrinsic value (as of 25 June 2025) is ₹542.48 — 16.67% lower the current market price of 651.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 52,832 Cr. market cap, FY2025-2026 high/low of ₹699/484, reserves of 29,054 Cr, and liabilities of 88,002 Cr.
What is the Market Cap of UPL Ltd?
The Market Cap of UPL Ltd is 52,832 Cr..
What is the current Stock Price of UPL Ltd as on 25 June 2025?
The current stock price of UPL Ltd as on 25 June 2025 is 651.
What is the High / Low of UPL Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of UPL Ltd stocks is ₹699/484.
What is the Stock P/E of UPL Ltd?
The Stock P/E of UPL Ltd is 48.8.
What is the Book Value of UPL Ltd?
The Book Value of UPL Ltd is 346.
What is the Dividend Yield of UPL Ltd?
The Dividend Yield of UPL Ltd is 0.15 %.
What is the ROCE of UPL Ltd?
The ROCE of UPL Ltd is 7.76 %.
What is the ROE of UPL Ltd?
The ROE of UPL Ltd is 4.01 %.
What is the Face Value of UPL Ltd?
The Face Value of UPL Ltd is 2.00.